Bioterrorism Handbook Revisions Archive

Below are a list of revision made to the Bioterrorism Handbook by date.

The following Centers for Disease Control and Prevention (CDC) link provides an Evaluation Tool of a Rash Illness Suspicious of Smallpox.

This evaluation tool includes six questions and criteria information for Clinicians. Caution: Use this tool only when there is no release or circulation of smallpox.
http://www.bt.cdc.gov/agent/smallpox/diagnosis/riskalgorithm/index.asp

Section V - Update Information

Notice to Readers: Use of Anthrax Vaccine in Response to Terrorism: Supplemental Recommendations of the Advisory Committee on Immunization Practices (ACIP), p. 33
- Overview: In December 2000, the ACIP released its recommendations for using anthrax vaccine in the U.S. Because of recent terrorist attacks involving the intentional exposure of U.S. civilians to Bacillus anthracis spores and concerns that the current anthrax vaccine supply is limited, ACIP developed supplemental recommendations on using anthrax vaccine in response to terrorism. These recommendations supplement the previous ACIP statement in three areas: use of anthrax vaccine for pre-exposure vaccination in the U.S. civilian population, the prevention of anthrax by post exposure prophylaxis (PEP), and recommendations for additional research related to using antimicrobial agents and anthrax vaccine for preventing anthrax.
Reference additions: Bozzette, S., et al. A Model for a Smallpox Vaccination Policy, N Engl J Med 2003: 348;5, Smallpox websites, pp. 94

Section VI.- Addendum